EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.1866
March 31, 2026 -0.1705
December 31, 2025 -0.1733
September 30, 2025 -0.2978
June 30, 2025 -0.1669
March 31, 2025 -0.2731
December 31, 2024 -0.3269
September 30, 2024 -0.3229
June 30, 2024 -0.2487
March 31, 2024 -0.488
December 31, 2023 -0.3915
September 30, 2023 -0.599
June 30, 2023 -0.5672
March 31, 2023 -0.8794
December 31, 2022 -2.672
September 30, 2022 -2.052
June 30, 2022 -2.157
March 31, 2022 -2.682
Date Value
December 31, 2021 -3.629
September 30, 2021 -3.450
June 30, 2021 -3.456
March 31, 2021 -6.027
December 31, 2020 -1.408
September 30, 2020 -3.939
June 30, 2020 -5.074
March 31, 2020 -4.454
December 31, 2019 -9.663
September 30, 2019 -4.289
June 30, 2019 -3.30
March 31, 2019 -2.959
December 31, 2018 -1.550
September 30, 2018 -1.613
March 31, 2018 -1.399
December 31, 2017 -0.8275
September 30, 2017 -0.9325
June 30, 2017 -3.482

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 2.268
Eli Lilly & Co. 7.939

EPS Diluted (Quarterly) Related Metrics